{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:59:14Z","timestamp":1785581954177,"version":"3.56.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Multiple sclerosis is a chronic neuroinflammatory disease associated with significant morbidity. Currently available pharmacotherapeutics are associated with several adverse effects. This letter discusses the potential of carboplatin, a platinum analog, which has recently shown promising results. We delve into the mechanisms of action and review the literature for potential adverse effects of carboplatin therapy.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003536","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:02:46Z","timestamp":1764838966000},"page":"7851-7852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Headway in multiple sclerosis therapy: the case for platinum analogues"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5968-4538","authenticated-orcid":false,"given":"Zain Ali","family":"Nadeem","sequence":"first","affiliation":[{"name":"Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0981-6650","authenticated-orcid":false,"given":"Umar","family":"Akram","sequence":"additional","affiliation":[{"name":"Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-3003","authenticated-orcid":false,"given":"Aalaa","family":"Saleh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lebanese University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-272X","authenticated-orcid":false,"given":"Aimen","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","first-page":"169\u201380","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20260801","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","journal-title":"Prem J Sci"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"110458","DOI":"10.1016\/j.intimp.2023.110458","article-title":"Carboplatin ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by inducing T cell apoptosis","volume":"121","author":"Lv","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"659\u201373","DOI":"10.1517\/14656566.2015.1002769","article-title":"Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs","volume":"16","author":"Milo","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"R5-20260801","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.3390\/ijms232315410","article-title":"Revisiting the anti-cancer toxicity of clinically approved platinating derivatives","volume":"23","author":"Forgie","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"6448\u201358","DOI":"10.1080\/21655979.2021.1972198","article-title":"Carboplatin activates the cGAS-STING pathway by upregulating the TREX-1 (three prime repair exonuclease 1) expression in human melanoma","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"key":"R7-20260801","first-page":"4978\u201386","article-title":"Mechanism of HN-3 cell apoptosis induced by carboplatin: combination of mitochondrial pathway associated with Ca2+ and the nucleus pathways","volume":"18","author":"Shen","year":"2018","journal-title":"Mol Med Rep"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"3069\u201374","DOI":"10.1002\/cncr.23935","article-title":"Use of platinum derivatives during pregnancy","volume":"113","author":"Mir","year":"2008","journal-title":"Cancer"},{"key":"R9-20260801","doi-asserted-by":"crossref","first-page":"445\u201348","DOI":"10.1089\/jayao.2019.0118","article-title":"Carboplatin use in pregnancy for stage IB3 cervical cancer: case report and review of the literature","volume":"9","author":"Rabaiotti","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R10-20260801","doi-asserted-by":"crossref","first-page":"196\u2013204","DOI":"10.1016\/j.lungcan.2019.07.010","article-title":"Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: a meta-analysis","volume":"135","author":"Griesinger","year":"2019","journal-title":"Lung Cancer"},{"key":"R11-20260801","doi-asserted-by":"crossref","first-page":"32\u201336","DOI":"10.1016\/j.jocn.2023.08.017","article-title":"A systematic review of the symptomatic management of Lhermitte\u2019s phenomenon","volume":"116","author":"Lam","year":"2023","journal-title":"J Clin Neurosci"},{"key":"R12-20260801","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood\u2013brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun"},{"key":"R13-20260801","first-page":"334\u201339","article-title":"Current and future immunotherapies for multiple sclerosis","volume":"118","author":"Bourque","year":"2021","journal-title":"Mo Med"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:12:07Z","timestamp":1785579127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003536","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"2025-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}